tiprankstipranks
Advertisement
Advertisement

AU:ILA Stock Latest News

Island Pharmaceuticals Wins FDA Orphan Status for Marburg Antiviral Galidesivir
Company AnnouncementsIsland Pharmaceuticals Wins FDA Orphan Status for Marburg Antiviral Galidesivir
6d ago
ILA
Island Pharmaceuticals Showcases New PROTECT Study Data at Asia Dengue Summit
PremiumCompany Announcements
Island Pharmaceuticals Showcases New PROTECT Study Data at Asia Dengue Summit
7d ago
ILA
Island Pharmaceuticals expands US army research pact to advance Marburg antiviral
PremiumCompany Announcements
Island Pharmaceuticals expands US army research pact to advance Marburg antiviral
13d ago
ILA
Island Pharmaceuticals advances Galidesivir with new GMP manufacturing deal
PremiumCompany Announcements
Island Pharmaceuticals advances Galidesivir with new GMP manufacturing deal
19d ago
ILA
Island Pharma hires ex-BioCryst leader to accelerate Galidesivir biodefence push
PremiumCompany Announcements
Island Pharma hires ex-BioCryst leader to accelerate Galidesivir biodefence push
1M ago
ILA
Island Pharmaceuticals Issues New Shares on Option Exercise, Affirms Regulatory Compliance
PremiumCompany AnnouncementsIsland Pharmaceuticals Issues New Shares on Option Exercise, Affirms Regulatory Compliance
2M ago
ILA
Island Pharmaceuticals Seeks ASX Quotation for 335,000 New Shares
Premium
Company Announcements
Island Pharmaceuticals Seeks ASX Quotation for 335,000 New Shares
2M ago
ILA
Island Pharmaceuticals secures FDA alignment and funding to advance Galidesivir biodefence program
Premium
Company Announcements
Island Pharmaceuticals secures FDA alignment and funding to advance Galidesivir biodefence program
2M ago
ILA
Island Pharmaceuticals Issues New Shares on Option Exercise, Affirms Regulatory Compliance
PremiumCompany Announcements
Island Pharmaceuticals Issues New Shares on Option Exercise, Affirms Regulatory Compliance
3M ago
ILA
Island Pharmaceuticals Seeks Quotation for Additional 125,000 ASX Shares
PremiumCompany Announcements
Island Pharmaceuticals Seeks Quotation for Additional 125,000 ASX Shares
3M ago
ILA
Island Pharmaceuticals Issues New Shares on Option Conversion, Affirms Compliance
PremiumCompany Announcements
Island Pharmaceuticals Issues New Shares on Option Conversion, Affirms Compliance
3M ago
ILA
Island Pharmaceuticals Seeks ASX Quotation for 690,000 New Shares
PremiumCompany Announcements
Island Pharmaceuticals Seeks ASX Quotation for 690,000 New Shares
3M ago
ILA
Island Pharmaceuticals Halts Trading Ahead of Biodefence Deal Announcement
PremiumCompany AnnouncementsIsland Pharmaceuticals Halts Trading Ahead of Biodefence Deal Announcement
4M ago
ILA
Island Pharmaceuticals posts wider half-year loss despite uptick in asset backing
Premium
Company Announcements
Island Pharmaceuticals posts wider half-year loss despite uptick in asset backing
4M ago
ILA
Island Pharmaceuticals Defends Handling of FDA Feedback in ASX Query
Premium
Company Announcements
Island Pharmaceuticals Defends Handling of FDA Feedback in ASX Query
4M ago
ILA
Island Pharmaceuticals Outlines Strategy on Urgent Viral Threats in Investor Presentation
PremiumCompany Announcements
Island Pharmaceuticals Outlines Strategy on Urgent Viral Threats in Investor Presentation
5M ago
ILA
Island Pharmaceuticals Plans New Share Placement to Raise Capital
PremiumCompany Announcements
Island Pharmaceuticals Plans New Share Placement to Raise Capital
5M ago
ILA
Island Pharmaceuticals Raises A$9m to Accelerate Galidesivir Biodefence Program and US Stockpile Push
PremiumCompany Announcements
Island Pharmaceuticals Raises A$9m to Accelerate Galidesivir Biodefence Program and US Stockpile Push
5M ago
ILA
FDA Backs Island Pharmaceuticals’ Galidesivir Pathway, Opening Route to Accelerated Approval
PremiumCompany Announcements
FDA Backs Island Pharmaceuticals’ Galidesivir Pathway, Opening Route to Accelerated Approval
5M ago
ILA
Island Pharmaceuticals Requests Trading Halt Ahead of FDA Feedback on Galidesivir
PremiumCompany AnnouncementsIsland Pharmaceuticals Requests Trading Halt Ahead of FDA Feedback on Galidesivir
5M ago
ILA
Island Pharmaceuticals Advances Clinical Programs Targeting Urgent Viral Threats
Premium
Company Announcements
Island Pharmaceuticals Advances Clinical Programs Targeting Urgent Viral Threats
5M ago
ILA
Island Pharmaceuticals Secures Key FDA Boost and US Partnerships for Galidesivir Antiviral Program
Premium
Company Announcements
Island Pharmaceuticals Secures Key FDA Boost and US Partnerships for Galidesivir Antiviral Program
5M ago
ILA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >